Drug-eluting stents versus bare metal stents.
作者信息
Conti C Richard
出版信息
Clin Cardiol. 2003 Nov;26(11):493-4. doi: 10.1002/clc.4960261102.
Abstract
摘要
相似文献
1
Drug-eluting stents versus bare metal stents.药物洗脱支架与裸金属支架
Clin Cardiol. 2003 Nov;26(11):493-4. doi: 10.1002/clc.4960261102.
2
Can we afford to eliminate restenosis? Can we afford not to?我们能否承担消除再狭窄的代价？我们能否承担不这样做的代价？
J Am Coll Cardiol. 2004 Feb 18;43(4):513-8. doi: 10.1016/j.jacc.2003.11.020.
3
Are drug-eluting stents cost-effective? It depends on whom you ask.药物洗脱支架具有成本效益吗？这取决于你问谁。
Circulation. 2006 Oct 17;114(16):1736-43; discussion 1744. doi: 10.1161/CIRCULATIONAHA.105.546010.
4
5
Drug-eluting stents: the price is not right.药物洗脱支架：价格不合理。
Circulation. 2006 Oct 17;114(16):1745-54; discussion 1754. doi: 10.1161/CIRCULATIONAHA.106.646190.
6
Drug-eluting stents substantially lower rate of restenosis.
Rep Med Guidel Outcomes Res. 2003 Oct 17;14(20):7-9.
7
The costs and quality-of-life outcomes of drug-eluting coronary stents: a systematic review.药物洗脱冠状动脉支架的成本及生活质量结果：一项系统评价
J Interv Cardiol. 2007 Feb;20(1):1-9. doi: 10.1111/j.1540-8183.2007.00214.x.
8
Drug-eluting versus bare-metal coronary stents: where are we now?药物洗脱支架与金属裸支架：现状如何？
J Comp Eff Res. 2012 Nov;1(6):501-8. doi: 10.2217/cer.12.64.
9
Predicting the restenosis benefit of drug-eluting versus bare metal stents in percutaneous coronary intervention.预测药物洗脱支架与裸金属支架经皮冠状动脉介入治疗的再狭窄获益。
Circulation. 2011 Oct 4;124(14):1557-64. doi: 10.1161/CIRCULATIONAHA.111.045229. Epub 2011 Sep 6.
10
Drug eluting stents: maximising benefit and minimising cost.药物洗脱支架：利益最大化与成本最小化
Heart. 2003 Feb;89(2):127-31. doi: 10.1136/heart.89.2.127.
引用本文的文献
1
Physician factors as an indicator of technological device adoption.作为技术设备采用指标的医生因素。
J Med Syst. 2006 Jun;30(3):177-86. doi: 10.1007/s10916-005-8066-2.
Zotero 插件